Literature DB >> 6374251

Platelet-activating factor-induced loss of glomerular anionic charges.

G Camussi, C Tetta, R Coda, G P Segoloni, A Vercellone.   

Abstract

The urinary protein excretion rate, the glomerular localization of cationic proteins (CP) derived from platelets and polymorphonuclear neutrophils (PMN) and the loss of fixed anionic charges were studied in rabbits infused with synthetic 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine [platelet activating factor (PAF), 1.5 micrograms/kg in 2 ml of saline containing 0.25% bovine serum albumin (BSA)]. The urinary protein excretion rate, unaffected by diphenhydramine, an antihistaminic agent, reached its maximum at 180 min and decreased 24 hr after PAF infusion. The localization of CP derived from platelets and PMN was investigated by immunofluorescence using specific antisera. Platelet-derived CP were detectable in glomeruli at 15 min and, particularly, at 180 min after PAF infusion. Cells positive for CP derived from PMN accumulated within 15 min in the glomerular capillaries and, later (180 min), cytoplasmic depletion and localization in glomerular capillary walls occurred. CP deposits were associated with the loss of fixed anionic charges as detected by ruthenium red and colloidal iron staining. Rabbits infused with 1-0-octadecyl-sn-glyceryl-3-phosphorylcholine (lyso-PAF) or saline-BSA alone had none of the alterations described above. The development of proteinuria, the glomerular localization of platelet- and PMN-derived CP and the concomitant loss of fixed anionic charges suggested the possibility that, once CP were released in the circulation from PAF-stimulated platelets and PMN, they bound to, and neutralized, fixed anionic charges, resulting in enhanced glomerular permeability.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6374251     DOI: 10.1038/ki.1984.10

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

Review 1.  Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?

Authors:  W W Bakker; W H van Luijk
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

2.  Experimental acute pancreatitis induced by platelet activating factor in rabbits.

Authors:  G Emanuelli; G Montrucchio; E Gaia; L Dughera; G Corvetti; L Gubetta
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

3.  Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man.

Authors:  J Arnout; A van Hecken; I De Lepeleire; Y Miyamoto; I Holmes; P De Schepper; J Vermylen
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

4.  Protection of platelet-activating factor-induced acute renal failure by BN 52021.

Authors:  E Pirotzky; P Colliez; C Guilmard; J Schaeverbeke; J M Mencia-Huerta; P Braquet
Journal:  Br J Exp Pathol       Date:  1988-04

5.  Human platelet cationic proteins bind to rat glomeruli, induce loss of anionic charges and increase glomerular permeability.

Authors:  C Tetta; R Coda; G Camussi
Journal:  Agents Actions       Date:  1985-03

Review 6.  Role of platelets in progressive glomerular diseases.

Authors:  C Zoja; G Remuzzi
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

7.  Activation of platelet-activating factor receptor exacerbates renal inflammation and promotes fibrosis.

Authors:  Matheus Correa-Costa; Vinicius Andrade-Oliveira; Tarcio T Braga; Angela Castoldi; Cristhiane F Aguiar; Clarice S T Origassa; Andrea C D Rodas; Meire I Hiyane; Denise M A C Malheiros; Francisco J O Rios; Sonia Jancar; Niels O S Câmara
Journal:  Lab Invest       Date:  2014-02-03       Impact factor: 5.662

Review 8.  The potential pathophysiological role of platelet-activating factor in human diseases.

Authors:  C Kroegel
Journal:  Klin Wochenschr       Date:  1988-05-02

9.  Attenuation of anti-Thy1 glomerulonephritis in the rat by anti-inflammatory platelet-inhibiting agents.

Authors:  K Poelstra; E Brouwer; J F Baller; M J Hardonk; W W Bakker
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

Review 10.  The role of platelet-activating factor (PAF) in experimental glomerular injury.

Authors:  A Ortiz; M Gomez-Chiarri; J L Lerma; E Gonzalez; J Egido
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.